YOUR GUIDE TO MESCALINE

3,4,5-TRIMETHOXYPHENETHYLAMINE

INTRODUCTION

Mescaline is the oldest psychedelic known to Western science. It is a pivotal substance that alters human relationships and consciousness. Mescaline is a naturally occurring alkaloid found in several cacti, such as peyote (Lophophora williamsii), San Pedro (Echinopsis pachanoi), and the Peruvian torch (Echinopsis peruviana). Indigenous peoples of the Americas have used it for ceremonial, spiritual, and healing purposes for at least 6,000 years [1].

Chemically, mescaline belongs to the phenethylamine class, structurally distinct from tryptamine psychedelics like psilocybin, DMT, or LSD. Still, it shares the same primary pharmacological mechanism: partial agonism at the brain's 5-HT₂A serotonin receptor [2]. Its effects are distinct, above all in color and sensory detail, rich closed-eye visual geometry, profound emotional openness, and a strong connection to nature. Unlike the brief, overwhelming totality of 5-MeO-DMT or the chemical precision of LSD, mescaline unfolds slowly and expansively over eight to twelve hours. This earns it a reputation as one of the most immersive and "earthed" psychedelic experiences [3].

Mescaline was the first psychedelic to be isolated and studied scientifically. This happened more than four decades before LSD's discovery [4]. However, modern research on mescaline is limited. Factors include the complexity of sourcing, legal concerns about Indigenous religious sovereignty, and its long-lasting effects. This imbalance is changing. Clinical interest is rising. Naturalistic surveys suggest therapeutic value. Ongoing discussion about conservation ethics and cultural respect is bringing mescaline into focus in psychedelic science and ethics today [5][6].

"IF THE DOORS OF PERCEPTION WERE CLEANSED, EVERYTHING WOULD APPEAR TO MAN AS IT IS - INFINITE."
— William Blake, quoted by Aldous Huxley in The Doors of Perception (1954)

THE HISTORY OF MESCALINE

The relationship between humans and mescaline-containing cacti stands among the longest and most continuous in psychoactive substance use history. Archaeological evidence, including carbon-dated peyote buttons from Shumla Caves in Texas and sites along the Rio Grande, confirms that people practiced ritual cactus use over 5,700 years ago, possibly as far back as 6,000 years [1]. Ceramic vessels and other artifacts from Andean sites in Peru and Ecuador demonstrate that cultures such as the Chavín and Tiwanaku widely used the San Pedro cactus across South America [7].

Spanish colonizers arrived in Mexico in the sixteenth century and reported widespread peyote use. Many Indigenous nations, including the Aztec and Huichol (Wixáritari), held ceremonies for prophecy, healing, and sacred communion using the cactus [8]. The Spanish Catholic Church viewed this as a threat to conversion and banned peyote ceremonies in 1620, marking the first drug prohibition in the Americas. Despite the ban, Indigenous peoples continued ceremonial use. By 1880, the Kiowa and Comanche introduced peyote into new intertribal ceremonies in the Great Plains [8]. In 1918, this practice crystallized in the Native American Church (NAC), a syncretic religious organization. Today, the NAC counts hundreds of thousands of members across the U.S. and Canada, for whom peyote remains a sacrament [9].

The Western scientific story of mescaline starts in 1896–1897 with German pharmacologist Arthur Heffter. He conducted self-experiments, isolating and identifying mescaline as the main psychoactive alkaloid in peyote. This made mescaline the first psychedelic compound to be scientifically characterized [4]. In 1919, Austrian chemist Ernst Späth achieved the first full laboratory synthesis. From then on, the compound no longer required the cactus as its source [10].

Mescaline research continued into the 1900s. In 1927, Heinrich Klüver carefully recorded mescaline’s geometric visual effects, naming the recurring patterns “form constants.” He also created terms for psychedelic experiences that are still used today [11]. In 1953, Aldous Huxley, under the supervision of psychiatrist Humphry Osmond in Los Angeles, took 400 mg of mescaline and described it in The Doors of Perception (1954). This book was key in introducing psychedelics to Western intellectual and literary culture, and is still one of the most influential accounts of psychedelic consciousness [12].

The 1950s and early 1960s brought some clinical research. Scientists studied mescaline as both a model psychosis and an agent for creative and spiritual insight. Alexander Shulgin said his early mescaline experiences inspired his later psychedelic research [13]. When LSD became available, it was preferred for being more potent, faster-acting, and cheaper. Mescaline then faded from scientific interest. In 1970, the U.S. Controlled Substances Act classified mescaline as Schedule I, and formal research stopped [9].

Mescaline is now seeing a cautious re-emergence. The first modern clinical trials began in the early 2020s. Naturalistic surveys show broad patterns of therapeutic benefit. Ethical questions about conservation and Indigenous sovereignty are raising new concerns. These factors shape who joins and profits from the renewed interest in this ancient molecule [5][6].

THE SCIENCE OF MESCALINE

PHARMACOLOGY

Mescaline (C₁₁H₁₇NO₃) is a substituted phenethylamine. It is the only major naturally occurring psychedelic in this chemical class, which also includes Alexander Shulgin's synthetic phenethylamines [2]. The molecule is structurally related to dopamine and other catecholamine neurotransmitters, but its main psychedelic action is serotonergic rather than dopaminergic. In pure synthetic form, mescaline is a white crystalline powder. Mescaline is the least potent of the classical psychedelics by weight. An effective oral dose is 200–400 mg for moderate effects and up to 1,000 mg for a full, ego-dissolving experience [3]. This reflects its moderate receptor binding compared to LSD or psilocybin, which are active at lower doses. Mescaline concentrations in peyote range from about 0.4% in fresh cactus to up to 6% dry weight. San Pedro usually contains 0.1-2%. Whole-cactus preparations are thus highly variable in dose [1].

PHARMACODYNAMICS

Mescaline acts as a partial agonist at serotonin 5-HT₂A receptors, the same receptors primarily responsible for the effects of LSD and psilocybin. This means that, like LSD and psilocybin, mescaline’s psychedelic effects rely on its action at 5-HT₂A receptors. The antagonist ketanserin's ability to block mescaline's effects confirms this [14]. Compared to other psychedelics, mescaline has relatively greater 5-HT₁A activity, which may explain its gentler, more "grounded" qualities that emphasize sensory enhancement over abstract cognitive disruption. Its receptor-binding profile is: 5-HT₁A > 5-HT₂A > 5-HT₂C > 5-HT₂B [2].

Unlike most classical psychedelics, mescaline does not inhibit serotonin, noradrenaline, or dopamine transporters. This sets it apart and may help explain its unique effect profile [2]. Animal studies suggest some dopaminergic involvement, as both serotonin and dopamine antagonists can blunt mescaline's effects. This area needs more research [2].

PHARMACOKINETICS

Most people take mescaline orally. A 2025 clinical study from the University Hospital Basel well characterized its pharmacokinetics [3]:

Absorption: Peak plasma concentrations are reached approximately 1.3–2.3 hours after ingestion. Absorption is dose-proportional across the range of 100–800 mg.
Distribution: The compound is distributed to the liver, spleen, and kidneys at substantially higher concentrations than in plasma. It crosses the blood-brain barrier readily due to its moderate lipophilicity.
Metabolism: Primary metabolism occurs via oxidative deamination to 3,4,5-trimethoxyphenylacetic acid (TMPAA). Researchers have also identified several minor metabolites [15].
Half-life: Plasma half-life is approximately 6 hours, though subjective effects substantially outlast plasma concentrations, consistent with the receptor-occupancy dynamics observed with other 5-HT₂A agonists [3].
Duration: Onset of effects typically begins 45–90 minutes after ingestion. The full experience lasts 8–12 hours, with higher doses increasing the duration. Many people report an afterglow of gentle perceptual enhancement and emotional openness that may extend for several additional hours [3].
Elimination: Excreted primarily in urine. The pharmacokinetic-pharmacodynamic relationship parallels that of LSD and psilocybin, consistent with shared 5-HT₂A agonism [3].

NEUROSCIENCE

Modern neuroimaging and EEG research on mescaline remains limited compared to psilocybin or LSD, but key findings are consistent with the broader classical psychedelic literature:

5-HT₂A mediation confirmed: A completed Phase 1 clinical trial at the University of Basel (NCT04849013) directly confirmed the role of 5-HT₂A receptors in mescaline's subjective effects using ketanserin pretreatment, establishing a foundation for understanding its mechanism comparable to existing LSD and psilocybin research [14].
Network changes: Like other classical psychedelics, mescaline is expected to increase inter-network connectivity and disrupt default mode network (DMN) coherence, though dedicated neuroimaging studies are still underway [5].
Form constants and visual cortex: Mescaline's distinctive geometric visual imagery, stripes, lattices, cobwebs, spirals, corresponds to activity patterns in the early visual cortex and was the subject of the first scientific phenomenology of psychedelic experience by Heinrich Klüver in the 1920s [11]. These patterns recur reliably across psychedelic states and may reflect fundamental modes of cortical self-organization.
Perceptual enhancement: Mescaline is particularly noted for its enhancement of color brilliance and sensory texture. These effects are distinct from the more cognitively disruptive properties of LSD and may reflect mescaline's unique receptor profile and its greater relative 5-HT₁A affinity [2].

LEGALITY, PSYCHOTHERAPY & MEDICAL USE

Mescaline is a Schedule I controlled substance under the U.S. Controlled Substances Act and is prohibited by the 1971 UN Convention on Psychotropic Substances, making it illegal in most countries [9]. The primary legal exception in the United States is for members of federally recognized Native American tribes using peyote in bona fide traditional religious ceremonies of the Native American Church, as protected by the American Indian Religious Freedom Act Amendments of 1994 (21 CFR § 1307.31) [9][16]. Synthetic mescaline, but not mescaline derived from cacti, was decriminalized in Colorado by Proposition 122 in November 2022. Several cities, including Oakland, California, have also decriminalized entheogenic plant medicines, including peyote [9].

Internationally, peyote is exempt from scheduling in Canada (though isolated or synthetic mescaline is controlled), and cactus plants are legal to grow as ornamentals in many European countries, though extraction for consumption remains illegal [9].

Despite mescaline's millennia-long history of use, clinical research remains strikingly sparse compared to other classical psychedelics. The first modern clinical trials began only in the early 2020s, led primarily by pharmacologist Matthias Liechti at the University Hospital Basel, including a comparison study of LSD, psilocybin, as well as a dedicated pharmacokinetic/pharmacodynamic study of oral mescaline hydrochloride [3][5].

Naturalistic survey data, however, is more developed. A 2021 survey of 452 adults who had used mescaline in naturalistic settings found that 68–86% of respondents with prior diagnoses of depression, anxiety, PTSD, alcohol use disorder, or drug use disorder reported subjective improvement following their most memorable mescaline experience. Improvements were significantly correlated with the intensity of acute mystical-type experience and with ratings of personal meaning [6].

Journey Colab, a California-based company, is developing a synthesized mescaline formulation (JOUR-5700) specifically for the treatment of alcohol use disorder, with an ascending-dose study planned, a logical target given the NAC's long-reported use of peyote in the treatment of alcoholism [5][17]. Biomind Labs has explored mescaline-derived compounds for inflammation-associated depression [5].

Mescaline faces distinctive clinical development challenges compared to psilocybin or ketamine: its long duration (8–12 hours) requires extended therapeutic supervision; its higher effective dose by weight requires careful pharmaceutical standardization; and the sourcing question, whether treatment should use synthetic mescaline, San Pedro-derived extracts, or peyote, involves both regulatory and ethical dimensions [5][6]. Several researchers have noted that these challenges, while real, do not diminish the molecule's therapeutic potential, and may ultimately be addressable through pharmaceutical formulation [5].

The ethical dimension of mescaline's clinical development is particularly important and deserves direct acknowledgment. Peyote is not simply a source of a chemical compound; it is a living sacrament to hundreds of thousands of people whose relationship with it predates the United States by millennia. Many Native American leaders and scholars have asked that peyote be excluded from psychedelic decriminalization and commercialization efforts, arguing that increased non-Indigenous access will further deplete already endangered wild peyote populations and appropriate sacred traditions [18]. For those interested in mescaline therapeutically, synthetic mescaline or San Pedro-sourced preparations avoid these concerns and remain the more ecologically and ethically sound choices.

RISKS & SIDE EFFECTS

Mescaline has a relatively favorable safety profile compared to many psychoactive compounds and has no known lethal dose in humans at experiential doses [3]. It is not considered physically addictive, and long-term NAC members have been documented using it for decades without developing tolerance or increased dependence [12]. Nevertheless, it carries meaningful psychological risks and requires serious preparation.

The most clinically significant risk is psychological: unsupported encounters with difficult emotional material during a 10-hour experience can be very destabilizing, particularly for those with undiagnosed or untreated mental health conditions. As with all classical psychedelics, individuals with a personal or family history of psychosis, schizophrenia, or bipolar disorder are strongly advised against use.

Nausea: Emesis and vomiting are among the most common physiological challenges with mescaline, especially with whole-cactus preparations. The alkaloid profile of raw cactus tissue (which includes alkaloids beyond mescaline) is considerably harder on the stomach than pharmaceutical-grade mescaline. Fasting, ginger tea, and the preparation of a more purified extract can significantly reduce this.

Cardiac effects: As a phenethylamine, mescaline has mild sympathomimetic properties, producing modest increases in heart rate and blood pressure [15]. These are not typically dangerous in healthy individuals but warrant caution for anyone with cardiovascular disease or hypertension.

Drug interactions: Combining mescaline with lithium carries seizure risk and is contraindicated. Combining with MAOIs may unpredictably potentiate effects and increase cardiovascular risk. Combining with stimulants amplifies cardiovascular strain [15].

PHYSIOLOGICAL EFFECTS:

Nausea and vomiting (particularly during onset, especially with cactus preparations)
Elevated heart rate and blood pressure
Dilated pupils
Increased body temperature and sweating
Muscle tension or mild tremor
Decreased appetite

PERCEPTUAL EFFECTS:

Intensification of colors to exceptional vividness
Geometric visual patterns and form constants (with eyes open and closed)
Synesthesia: sounds acquiring color, texture, or visual form
Altered sense of time
Fractal-like perception of surfaces and natural forms
Enhanced sensory detail across all modalities

COMMON SIDE EFFECTS:

Acute anxiety or fear in unprepared individuals or challenging environments
Surfacing of unprocessed emotional material
Disorientation during the long duration, particularly if set or setting deteriorates
Rare: persistent perceptual disturbances (HPPD)
Psychological destabilization if the experience is not integrated

HARM REDUCTION & RESPONSIBLE USE

If someone chooses to use mescaline despite legal restrictions, the following harm reduction principles apply. The long duration of mescaline makes advance preparation especially important; there is no shortening or interrupting an experience once it is underway.

SAFETY & GROUNDING

Know your source and your dose. Whole cactus preparations vary enormously in mescaline content, even between segments of the same cactus. Pharmaceutical-grade synthetic mescaline allows precise dosing; San Pedro preparations are more variable than peyote.
Use a reagent test kit (Marquis or Mecke) to confirm the authenticity of synthetic material.
Have a sober, experienced trip sitter present, particularly for first experiences or higher doses.
Arrange your space thoughtfully: a comfortable, private environment with outdoor access if possible. Remove obligations for the full day.
Keep water, light food, and music accessible.

PREPARATION & MINDSET

Fast lightly for 4–6 hours before ingestion to reduce nausea. Avoid fatty foods.
Set a clear intention but hold it lightly. Mescaline is not a substance that submits easily to an agenda.
Avoid combining with alcohol, stimulants, MAOIs, or lithium.
Plan for 12+ hours: 10 for the experience, time afterward for rest and orientation.
Consider ginger supplements or ginger tea to reduce nausea during the onset.

DOSE REFERENCE (Oral, synthetic mescaline HCl)

Threshold: 100–150 mg* Light: 150–200 mg
Moderate: 200–300 mg
Strong: 300–500 mg
Very strong/ego dissolution: 500–1,000 mg (Whole San Pedro or peyote preparations require substantially higher weights due to lower mescaline concentration)

A NOTE ON SOURCING AND ETHICS

Peyote (Lophophora williamsii) is a slow-growing cactus that takes 10–30 years to mature in the wild and is currently over-harvested and endangered in its native range in south Texas and northern Mexico [18]. Wild peyote populations are under real ecological pressure from both overharvesting and habitat loss. For those outside Indigenous ceremonial traditions, choosing synthetic mescaline or San Pedro-derived preparations, rather than peyote, is both the more ecologically responsible and the more culturally respectful choice. This is not merely an ethical nicety; it is a matter of conservation urgency [18].

MESCALINE, MYSTICISM & SPIRITUALITY

Mescaline has a longer documented history of sacred use than virtually any other substance in the psychedelic canon. For the Huichol (Wixáritari) people of the Sierra Madre, peyote is not simply a medicine or a drug; it is Hikuri, a living deity, the heart of their cosmology, and the means by which the community renews its relationship with the sacred landscape of Wirikuta, the desert homeland to which the peyote pilgrimage travels each year [7]. For the hundreds of thousands of members of the Native American Church, the all-night ceremony, the peyote meeting, is the central practice of a living religious tradition [9].

Aldous Huxley's The Doors of Perception brought this dimension of mescaline into Western cultural consciousness in 1954. Drawing on

Henri Bergson's concept of the brain as a "reducing valve," an idea later echoed by Hofmann in his reflections on LSD, Huxley proposed that mescaline opened perception to what he called "Mind at Large": the full richness of reality that ordinary consciousness habitually filters out in the interest of survival [12]. His account remains one of the most lucid and philosophically serious first-person descriptions of a psychedelic state.

Neuroscience offers a mechanism for this phenomenology: mescaline's disruption of the brain's predictive coding systems, the top-down filtering that normally constrains raw sensory input, allows more information to reach conscious awareness, producing the quality of renewed, unfiltered perception that Huxley described [14]. The rich color enhancement and geometric visual forms may reflect the visual cortex operating with reduced top-down inhibition, allowing spontaneous pattern generation to become visible.

Naturalistic survey data confirms what centuries of ceremonial use suggest: the intensity of mystical experience during mescaline use is among the strongest predictors of long-term benefit. Respondents who reported improvements in depression, anxiety, and PTSD attributed those improvements significantly to the depth of their sense of meaning, unity, and sacredness during the experience [6].

HOW TO PREPARE FOR YOUR MESCALINE TRIP

Mescaline's long duration makes it, in some ways, the most demanding of the classical psychedelics to prepare for, and perhaps the most richly rewarding when that preparation is done well. The experience is long enough to be a kind of retreat unto itself.

1. CHOOSE YOUR FORM THOUGHTFULLY

Synthetic pharmaceutical-grade mescaline offers precise, predictable dosing. San Pedro-derived preparations are widely available, ecologically less fraught than peyote, and can be prepared at home, though they require careful standardization. Whatever you choose, know your source, test your material, and understand what you're ingesting.

2. SET YOUR INTENTION

Mescaline tends to respond to intention, not to dictate where the experience goes, but to orient it. A meaningful question, a dedication to someone you love, an openness to a particular aspect of your life, these act as seeds that the experience can grow around. Hold the intention clearly at the outset, then let it go.

3. PLAN YOUR DAY...AND THE DAY AFTER

Begin in the morning to ensure the experience resolves before bedtime. Allow for quiet, unhurried time the following day as well, the afterglow and the integration process both benefit from space. Avoid scheduling anything demanding, social, or emotionally complex for at least 24 hours.

4. TEND TO THE BODY

Eat lightly or fast for several hours before ingestion. Some people find mescaline much easier on the stomach with ginger tea, anti-nausea medication (such as ondansetron, taken 30–60 minutes before ingestion), or by preparing a purified extract rather than raw cactus material. Hydrate well in the days leading up to the experience.

5. YOUR ENVIRONMENT

Mescaline loves the natural world. Access to a garden, a park, or open countryside during the peak and plateau significantly enriches the experience for most people. Design your space to include both interior comfort and the possibility of time outside. Prepare playlists, art materials, a journal, whatever channels you feel drawn to express through.

6. YOUR SITTER

A sober, trusted companion, ideally one with their own psychedelic experience, is strongly recommended, especially for doses above 200 mg or first-time experiences. Their role is not to guide the experience but to be a calm, reliable presence: someone who knows where you are, can offer reassurance if needed, and can respond practically if anything goes wrong.

THE MESCALINE EXPERIENCE

Of all the classical psychedelics, mescaline is perhaps the most consistently described as "beautiful." Where LSD can be cerebral and analytical, psilocybin interior and emotional, and 5-MeO-DMT overwhelming and structureless, mescaline tends toward sensory rapture, a slow, thorough illumination of the world as it already is, stripped of the film of habituation that normally dulls perception.

Colors intensify to an almost painful vividness. Surfaces appear to breathe with microscopic texture. Natural forms, a leaf, a piece of bark, the grain of a wooden table, reveal complexity that ordinarily passes unnoticed. Aldous Huxley described, in his 1953 experience, watching a vase of flowers become "a miracle, moment by moment, of naked existence" [12]. This quality of seeing the ordinary as sacred, the familiar as inexhaustibly strange, is among mescaline's most characteristic and most reported gifts.

The experience is also deeply emotional. Many users describe waves of gratitude, love, and a profound sense of connection to other people, to the natural world, and to something larger than personal identity. Some encounter difficult emotional material: grief, fear, or confrontation with unresolved experience. The long duration gives both gifts and challenges room to develop fully.

THE ONSET (0 – 90 MIN)

Mescaline is slow to arrive. The first 30–45 minutes after ingestion are typically neutral, followed by a gradual intensification. The first signals are subtle: a brightening at the edges of perception, a heightening of color, a subtle sharpening of sound, occasionally a wave of mild warmth or anxiety as the body registers the arrival of something unfamiliar. Nausea can often accompany the initial absorption phase, particularly with whole-cactus preparations, and can be significant. It typically resolves as the experience deepens. Remaining still, breathing slowly, and having a basin nearby are practical preparations. As the effects develop, a sense of anticipation and aliveness builds. By the 90-minute mark, the full experience is usually well underway.

THE PEAK (2 – 6 HRS)

The peak arrives gently but fully, typically occurs 2 to 4 hours after ingestion, and can last for several hours. Visual phenomena are vivid and complex: with eyes open, surfaces ripple and pulse; with eyes closed, elaborate geometric patterns, mandalas, lattices, spiraling kaleidoscopes of color, unfold with extraordinary precision and beauty. Synesthesia is common: sounds acquire color and texture; music feels tactile or visual. Time slows and expands; a single hour may feel like a vast territory of experience.

Emotionally and cognitively, the peak is often described as a state of profound presence, a sense that ordinary perception has been stripped of its filters and the world is being seen clearly, perhaps for the first time. Many people feel a deep kinship with the natural world, with other living beings, and with the continuity of life. Others encounter more personal territory: family history, grief, values, vocation. Both are valid expressions of the experience.

THE PLATEAU (5 – 9 HRS)

After the peak, mescaline typically settles into a long, lucid plateau in which the intensity of acute effects moderates but the quality of perception remains profoundly altered. This phase is often experienced as one of the most rewarding: conversation, music, movement, and time in nature all feel deeply meaningful. Creative expression (drawing, writing, music) can arise naturally. The plateau is also when much of the reflective work of a mescaline experience occurs.

THE DESCENT (8 – 12+ HRS)

The return to ordinary consciousness is gradual, in keeping with mescaline's character. Colors slowly normalize, the sense of heightened presence recedes, and the body registers the exertion of a long experience: appetite returns, fatigue sets in. Many people describe the afterglow of a mescaline experience as particularly warm and clear, a sense of refreshed perception and emotional openness that can persist for days.

The long duration of mescaline is one of its most important practical considerations. A full experience requires setting aside an entire day; from morning ingestion to early sleep is a reasonable template. Attempting to compress, interrupt, or rush the experience creates risk and diminishes value.

NAVIGATING A CHALLENGING TRIP

Even with excellent preparation, mescaline can surface difficult emotional content. The same long duration that makes it richly exploratory also means that discomfort, if it arises, has time to develop.

Useful orienting principles:

Remember that difficulty is part of the experience, not an emergency. Most hard passages resolve within an hour. Surrender is more effective than resistance. The experience cannot be shortened by fighting it.
Change the input: adjust music, move to a different space, step outdoors.
Breathe deliberately and return attention to the body.
Speak with your sitter. spoken reassurance and physical presence from a trusted person are very effective.
If the experience feels genuinely unmanageable, a small oral dose of a benzodiazepine (with a sitter present) can reduce intensity without fully terminating the experience.
If needed, the Fireside Project (US-based, free, confidential psychedelic peer support line) is available throughout an experience.

WHAT TO EXPECT

INTEGRATING THE EXPERIENCE

A mescaline experience is long enough to constitute a significant inner event, and integration, the process of understanding and embodying what occurred, deserves time and attention proportional to the depth of what was encountered.

Rest first. The day or two after a mescaline experience calls for quiet, not analysis. Let the experience settle before reaching for meaning.
Journal. Write freely and without editing, what you saw, what you felt, what surprised you, what unsettled you. Return to these notes over subsequent weeks as the experience continues to yield meaning.
Speak with someone. A trained integration therapist, a trusted friend with psychedelic experience, or a peer integration circle can provide the reflection needed to deepen understanding.
Attend to what was shown. If the experience surfaced a recurring theme, a relationship, a grief, a question about direction, treat that as information. Integration is not completed in a journal entry; it is enacted in changed behavior over time.
Spend time in nature. Mescaline's deep affinity for the natural world often leaves behind an enhanced ecological sensitivity, a renewed awareness of beauty and interconnection that is itself valuable and worth tending.
Be patient with the timeline. The full meaning of a mescaline experience can take months to fully clarify. Give it that time without forcing conclusions.

Sources

PHARMAKOGNOSIS